You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Zoledronic Acid as Adjuvant Therapy in Combination with Adjuvant Endocrine Therapy for Premenopausal Women with Early-Stage Hormone Receptor Positive Breast Cancer

ID: CED 16 Jan 2010
Type of Content: Guidelines & Advice, Clinical
Document Status: Archived
Authors:
M. Clemons, E. Amir, A.E. Haynes, A. Eisen, M. Trudeau